Inclusion body myositis (IBM) is a rare, progressive muscle disorder that affects the muscles of the arms and legs. It is characterized by muscle weakness, atrophy, and pain. It is a slowly progressing condition, and its cause is unknown. IBM is often misdiagnosed due to its rarity and the fact that its symptoms can mimic those of other muscle diseases. IBM is believed to be an autoimmune disorder, in which the body's own immune system attacks healthy muscle tissue. This causes inflammation and damage to the muscle fibers, leading to muscle weakness and atrophy. IBM is more common in males than females, and usually affects people over the age of 50. IBM is not curable, but treatments are available to help manage its symptoms. Treatment options include physical therapy, exercise, medications to reduce inflammation, and assistive devices such as wheelchairs and canes.
The exact cause of IBM is unknown, but it is believed to be an autoimmune disorder. In this type of disorder, the body's own immune system mistakenly attacks healthy muscle tissue, leading to inflammation and damage to the muscle fibers. Other risk factors for IBM include age, gender, and genetics. IBM is more common in males than females, and usually affects people over the age of 50. There is also a genetic component to the disorder, as some people are more likely to develop IBM if they have a family history of the disorder.
IBM is a slowly progressing condition, and its symptoms can vary from person to person. Common symptoms of IBM include muscle weakness, muscle pain, and muscle atrophy. Other symptoms can include difficulty walking, difficulty rising from a seated position, difficulty with fine motor tasks, and difficulty gripping objects.
IBM can be difficult to diagnose due to its rarity and the fact that its symptoms can mimic those of other muscle diseases. To diagnose IBM, the doctor will perform a physical exam and order blood tests and imaging tests such as an MRI or CT scan. These tests can help the doctor determine if there is any inflammation or damage to the muscles. The doctor may also order a muscle biopsy, in which a small sample of muscle tissue is taken for examination. This can help the doctor confirm the diagnosis of IBM and rule out other muscle diseases.
Treatment
There is no cure for IBM, but treatments are available to help manage its symptoms. Treatment options include physical therapy, exercise, medications to reduce inflammation, and assistive devices such as wheelchairs and canes. Physical therapy can help maintain muscle strength and function, and can also help reduce pain and improve mobility. Exercise can also help maintain muscle strength and function, and can help improve overall health. Medications such as corticosteroids and non-steroidal anti-inflammatory drugs (NSAIDs) can help reduce inflammation and pain. Assistive devices such as wheelchairs and canes can help improve mobility and independence.
Since the exact cause of IBM is unknown, there is no way to prevent the disorder. However, there are some steps that can be taken to reduce the risk of developing IBM. These include maintaining a healthy lifestyle, eating a balanced diet, and exercising regularly. It is also important to be aware of the signs and symptoms of IBM, and to seek medical attention if any of these symptoms are present.
Inclusion body myositis (IBM) is a rare, progressive muscle disorder that affects the muscles of the arms and legs. It is characterized by muscle weakness, atrophy, and pain. The exact cause of IBM is unknown, but it is believed to be an autoimmune disorder. IBM is not curable, but treatments are available to help manage its symptoms. These include physical therapy, exercise, medications to reduce inflammation, and assistive devices such as wheelchairs and canes. There is no way to prevent IBM, but maintaining a healthy lifestyle, eating a balanced diet, and exercising regularly can help reduce the risk of developing the disorder.
1.
Certain surgical gestures during prostate removal linked to better sexual function recovery
2.
There has been a recent decrease in the risk of a recurrence of colorectal cancer in stage I to III cases.
3.
In patients with advanced lung cancer, cemiplimab combined with chemotherapy extends life and enhances quality of life.
4.
An "exploding" field of antibody-drug conjugates is making progress against ovarian cancer.
5.
Black women have a higher risk of dying from all types of breast cancer, meta-analysis reveals
1.
Trends in Incidence, Care, and Surgery for Medullary Thyroid Cancer: A Review
2.
Surgery for Tracheoesophageal Fistula: What to Expect Before, During, and After
3.
What Is A Normal Fibrinogen Level, And How Can It Affect Your Health
4.
Breakthroughs in Cancer Care: From Rare Diagnoses to Advanced and Early-Stage Treatments
5.
ERASur: Evaluating Total Ablative Therapy in Limited Metastatic Colorectal Cancer
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
2.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI
4.
Current Scenario of Cancer- Q&A Session to Close the Gap Part II
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation